Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of Oncology. (Q43250098)
Jump to navigation
Jump to search
scientific article published on 2 November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of Oncology. |
scientific article published on 2 November 2009 |
Statements
Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of Oncology (English)
B Martin-Castillo
J Dorca
A Vazquez-Martin
C Oliveras-Ferraros
E Lopez-Bonet
M Garcia
2 November 2009